Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTOG-9111: Larynx Preservation Trial
NCT00002496Phase 3Completed
- Sponsor
- NRG Oncology
- Start
- Aug 1992
- Primary completion
- Aug 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of cisplatin, fluorouracil in laryngeal squamous cell carcinoma (LSCC), sponsored by NRG Oncology. Started Aug 1992; status: completed.
02
Drugs
cisplatinfluorouracil
03
Conditions
laryngeal squamous cell carcinoma (LSCC)
Beyond the preview
Go deeper on NCT00002496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002496.